Literature DB >> 6702934

The cytologic history of 245 patients developing invasive cervical carcinoma.

J A Carmichael, J F Jeffrey, H D Steele, I D Ohlke.   

Abstract

A review was made of the cytologic history of 245 patients who developed invasive carcinoma of the cervix, and three groups of patients were identified. Group 1 included 149 patients (60.8%) who had never had a cervical cytologic examination, group 2 included 26 patients (10.6%) whose cytologic history in terms of frequency of examination and or timing was considered to be unsatisfactory, and group 3 included 70 patients (28.6%) whose cytologic history was considered to be satisfactory. Only 53 (35.6%) of the patients in group 1 had Stage I disease. Stage I disease was present in 16 patients (61.5%) of group 2 and in 55 patients (78.6%) of group 3. There was no significant difference between the three groups with respect to site of residence or access to the health care system. Of the patients in group 3, 20 (28.6%) had normal cytologic findings and 50 (71.4%) had abnormal cytologic findings. Of the 50 patients with abnormal cytologic findings, 31 (62.0%) did not have further examination for 6 months or longer after identification of the abnormal smear. The majority of these patients had minor degrees of cytologic abnormalities. A review of 299 original cervical smears revealed that 52 (17.4%) had been significantly undercalled, but only 21 (7.0%) had been undercalled as normal. In this study, 28 patients (11.4%) developed adenocarcinoma. In these patients, staging was unrelated to screening.

Entities:  

Mesh:

Year:  1984        PMID: 6702934     DOI: 10.1016/0002-9378(84)90774-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

Review 1.  Report of a National Workshop on Screening for Cancer of the Cervix.

Authors:  A B Miller; G Anderson; J Brisson; J Laidlaw; N Le Pitre; P Malcolmson; P Mirwaldt; G Stuart; W Sullivan
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

2.  Review of the screening history of Alberta women with invasive cervical cancer.

Authors:  G C Stuart; S E McGregor; M A Duggan; J G Nation
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

3.  Failures of cervical cancer screening.

Authors:  A B Miller
Journal:  Am J Public Health       Date:  1995-06       Impact factor: 9.308

4.  'Before you teach me, I cannot know': immigrant women's barriers and enablers with regard to cervical cancer screening among different ethnolinguistic groups in Canada.

Authors:  Lynda Redwood-Campbell; Nancy Fowler; Stephanie Laryea; Michelle Howard; Janusz Kaczorowski
Journal:  Can J Public Health       Date:  2011 May-Jun

Review 5.  Pap test results. Responding to Bethesda system reports.

Authors:  T J Colgan
Journal:  Can Fam Physician       Date:  2001-07       Impact factor: 3.275

6.  Revisiting the effect of the Pap test on cervical cancer.

Authors:  N D Holmquist
Journal:  Am J Public Health       Date:  2000-04       Impact factor: 9.308

7.  Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population.

Authors:  Karin Nelson; Ann M Geiger; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

8.  Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.

Authors:  P Zazove; B D Reed; L Gregoire; A Ferenczy; D W Gorenflo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 9.  Cervical cancer prevention--cervical screening: science in evolution.

Authors:  Mahboobeh Safaeian; Diane Solomon; Philip E Castle
Journal:  Obstet Gynecol Clin North Am       Date:  2007-12       Impact factor: 2.844

10.  Prophylactic cytological investigation for cervical cancer in relation to stage at diagnosis: a study of 420 women in Denmark.

Authors:  F Olesen
Journal:  J R Coll Gen Pract       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.